Table 3.
Treatment and visual outcomes of EE-related PLA patients.
| Patient No | Eye affected | Initial VA (OS/OD) | Final VA (OS/OD) | Intravitreally injected antibiotic | Respond of treatment | Operation |
|---|---|---|---|---|---|---|
| 1 | OS, OD | PL/HM | NPL/CF 10 cm | VAN (OS, 4 times), VAN (OD, 1 time) | Worse (OS), Better (OD) | None |
| 2 | OS | NPL/0.2 | NPL/0.2 | CEF (OS, 3 times) | No change | None |
| 3 | OD | 0.6/HM | 0.6/PL | CEF (OD, 1 time), VAN (OD, 2 times) | No change | None |
| 4 | OS, OD | PL/PL | NPL/PL | AMK (OS, 3 times) | Worse | None |
| 5 | OD | 0.2/HM | 0.2/HM | CEF (OD, 3 times) | No change | None |
| 6 | OD | 0.2/NPL | 0.2/NPL | CEF (OD, 3 times) | No change | None |
| 7 | OS, OD | NPL/0.7 | NPL/0.7 | AMK (OS, 2 times) | No change | None |
| 8 | OS | PL/0.2 | NPL/0.2 | CEF (OS, 3 times) | Worse | Enucleation |
| 9 | OD | 0.2/0.1 | 0.2/NPL | CEF (OD, 3 times) | Worse | Enucleation |
| 10 | OD | 0.1/NPL | 0.28/NPL | Vancomycin (OD, 3 times) | Better | None |
| 11 | OS | 0.2/NPL | 0.25/NPL | Ceftazidim (OS, 3 times) | No change | None |
| 12 | OS | CF1.5 m/0.28 | 0.13/0.2 | Ceftazidim (OS, 3 times) | Better | None |
VA: visual acuity; OS: left eye; OD: right eye; HM: hand motion; CF: counting finger vision; NPL: no perception light; PL: perception light; VAN: vancomycin; CEF: ceftazidime; AMK: amikacin.